MedTrace Logo

Assessment of Blood Glucose Monitoring Devices With New Insight Features

NCT02929654 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 267

Last updated 2017-08-15

No results posted yet for this study

Summary

To investigate whether novel insight features in new BGMs can improve glycemic control.

Conditions

Interventions

DEVICE

OneTouch Verio®

Colour Enhanced Blood Glucose Meter.

DEVICE

OneTouch Verio® Flex

Colour Enhanced Blood Glucose Meter.

DEVICE

Subject's Own Blood Glucose Meter

Subject's Own Blood Glucose Meter

Sponsors & Collaborators

  • LifeScan

    lead INDUSTRY

Principal Investigators

  • Mike Grady · LifeScan Scotland

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-01
Primary Completion
2017-06-22
Completion
2017-06-22

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02929654 on ClinicalTrials.gov